Cite Score:
0.28
ELSEVIER SCOPUS

Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?

AUTHORS

Brenda Morrow 1 , *

AUTHORS INFORMATION

1 Department of Pediatric Medicine, University of Cape Town, Cape Town, South Africa

ARTICLE INFORMATION

Journal of Comprehensive Pediatrics: 4 (4); e93768
Published Online: November 01, 2013
Article Type: Letter
Received: May 15, 2019
Accepted: August 28, 2013
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Cystic fibrosis (CF) is recognized as a serious, life-limiting autosomal recessive inherited condition, affecting multiple organs. Improvements in both diagnosis and management of CF has led to the recognition of a range of phenotypes, from mild to severe, with varying rates of disease progression. Pulmonary disease is still the main predictor of morbidity and mortality associated with CF (1). There are currently nearly 2000 recognized cystic fibrosis trans-membrane regulator (CFTR) mutations.

Keywords

Cystic Fibrosis Shwachman

© 2013, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
References
  • 1. The references are available in PDF file.
  • COMMENTS

    LEAVE A COMMENT HERE: